Blog
Pre-Markets Dip on GDP & PCE Figures
Friday, February 20th, 2026Economic indexes had been on a roll lately, putting up better-than-expected figures on growth, productivity, employment and so on. That appears to have come to an end this
Insmed Lags on Q4 Earnings, Stock Gains on 2026 Brinsupri Sales View
Insmed INSM reported a fourth-quarter 2025 loss of $1.54 per share, wider than the Zacks Consensus Estimate of a loss of $1.07. In the year-ago quarter, the company had incurred a loss of $1.32.
ETSY Q4 Earnings & Revenues Surpass Estimates, EPS Declines Y/Y
Etsy ETSY reported fourth-quarter 2025 earnings of 92 cents per share, which beat the Zacks Consensus Estimate by 4.55% but declined 10.68% year over year.Fourth-quarter 2025 revenues increased
MercadoLibre Set to Report Q4 Earnings: Hold or Fold the Stock?
MercadoLibre MELI is slated to report fourth-quarter 2025 results on Feb. 24.The Zacks Consensus Estimate for fourth-quarter revenues is pegged at $8.52 billion, suggesting year-over-year growth of
LKQ Q4 Earnings Miss Expectations, Revenues Decline Y/Y
LKQ Corporation LKQ delivered fourth-quarter 2025 adjusted earnings of 59 cents per share, which missed the Zacks Consensus Estimate of 65 cents and declined from 80 cents reported in the year-ago
Chart Industries (GTLS) Earnings Expected to Grow: What to Know Ahead of Q4 Release
The market expects Chart Industries (GTLS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ANI Pharmaceuticals (ANIP) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus
Best Momentum Stocks to Buy for February 20th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 20:
Phibro Animal Health Corporation PAHC: This animal health and mineral nutrition
Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down
Madrigal Pharmaceuticals MDGL reported a fourth-quarter 2025 loss of $2.57 per share, in contrast to the Zacks Consensus Estimate of earnings of 4 cents. The large difference is mainly due to a
Pediatrix Medical Q4 Earnings Miss Estimates Despite Declining Costs
Pediatrix Medical Group, Inc. MD reported fourth-quarter 2025 adjusted earnings per share (EPS) of 50 cents, which missed the Zacks Consensus Estimate by 4.9%. The bottom line declined 2% year over
Wayfair Q4 Earnings & Revenues Beat Estimates, Increase Y/Y
Wayfair W reported fourth-quarter 2025 non-GAAP earnings of 85 cents per share, which beat the Zacks Consensus Estimate by 32.8% and marked a significant improvement from a non-GAAP adjusted diluted
Best Low-Beta Stocks to Own Right Away: CBOE, AU, SKM & SSL
Investor sentiment has been weighed down by concerns over risky private loans and rising oil prices stemming from escalating tensions between the United States and Iran, according to CNBC.Thus, the
Wall Street Analysts See a 29.32% Upside in Copa Holdings (CPA): Can the Stock Really Move This High?
Copa Holdings (CPA) closed the last trading session at $139.34, gaining 4.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Think EuroDry (EDRY) Could Surge 35.09%: Read This Before Placing a Bet
Shares of EuroDry (EDRY) have gained 27.6% over the past four weeks to close the last trading session at $16.9, but there could still be a solid upside left in the stock if short-term price targets
How Much Upside is Left in Hinge Health Inc. (HNGE)? Wall Street Analysts Think 38.96%
Shares of Hinge Health Inc. (HNGE) have gained 0.4% over the past four weeks to close the last trading session at $41.92, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts Predict a 27.09% Upside in Brookdale (BKD): Here's What You Should Know
Brookdale Senior Living (BKD) closed the last trading session at $14.95, gaining 17.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Wall Street Analysts Think Insmed (INSM) Could Surge 33.6%: Read This Before Placing a Bet
Insmed (INSM) closed the last trading session at $161, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Should You Buy Redwood Trust (RWT) After Golden Cross?
After reaching an important support level, Redwood Trust, Inc. (RWT) could be a good stock pick from a technical perspective. RWT recently experienced a "golden cross" event, which saw its 50-day
Wall Street Analysts See a 30.39% Upside in Rush Street Interactive (RSI): Can the Stock Really Move This High?
Rush Street Interactive, Inc. (RSI) closed the last trading session at $18.66, gaining 5.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Should You Buy Equinix (EQIX) After Golden Cross?
Equinix, Inc. (EQIX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, EQIX's 50-day simple moving average crossed above its
Here's Why Sage Group (SGPYY) Is a Great 'Buy the Bottom' Stock Now
Shares of Sage Group PLC (SGPYY) have been struggling lately and have lost 7.2% over the past two weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that
Here's Why Zebra Technologies (ZBRA) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why HCA Healthcare (HCA) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Lockheed Martin (LMT) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Why Transocean (RIG) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates


